Chicagoest,

nice find.  Corporate states 'We are actively seeking non-dilutive financing options to fund apabetalone’s clinical programs, including co-development, licensing, rights or other partnering arrangements, and procurement arrangements.'  How can finding a partner be "non-dilutive"?  Partner will want 50% of the earnings.  Any time you share earnings, that is dilutive. They call themselves management, give me a break.

The real asset of Resverlogix was the employees who developed Apabetalone and the other compounds on the shelf.  What has happened to those employees?  Really, really sad how greed can destroy good benefits.  sidebar